Verrica Pharmaceuticals Inc.
VRCA· Nasdaq
Verrica Pharmaceuticals Inc.
- Last sale
- Oct 1, 2026 · -3.45%
- Market cap
- $81.77M
- 17.18M shares
- Filings
- 534
Price
Oct 1, 2026 · IEX last sale
IEX last saleClose of record
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $35,577,000 | reported | |
| FY 2024 | 2024-12-31 | $7,566,000 | reported | |
| FY 2023 | 2023-12-31 | $5,124,000 | reported | |
| FY 2022 | 2022-12-31 | $9,032,000 | reported | |
| FY 2021 | 2021-12-31 | $12,000,000 | reported |
Verrica Pharmaceuticals Inc. · CIK 1660334 · Engraved from SEC EDGAR
